Regardless of the mechanism involved in inhibiting Fbw7-γ turnover, as c-Myc is a proto-oncogene and is often overexpressed or amplified in tumor cells [39], an intriguing possibility to control c-Myc protein levels might involve regulation of the abundance of Fbw7-γ and SLP-1. The gene discussed is STOML1; the disease is neoplasm.